FDA Inspection 626356 — Biomat USA, Inc

Biomat USA, Inc — FEI 1643256

The FDA completed an inspection of Biomat USA, Inc on October 22, 2009 in McAllen, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 22, 2009
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
McAllen, TX (United States)

Citations

IDCFRDescription
25521 CFR 640.31Donor eligibility
904421 CFR 600.10(b)Personnel capabilities